Suppr超能文献

在加拿大药品和技术评估署设立患者和社区咨询委员会。

Creating a patient and community advisory committee at the Canadian Agency for Drugs and Technologies in Health.

机构信息

Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Ave, Ottawa, Ontario, CanadaK1S 5S8.

出版信息

Int J Technol Assess Health Care. 2021 Jan 22;37:e19. doi: 10.1017/S0266462320002251.

Abstract

In recognition of patients' roles using, and contributing to, a publicly funded health system, the Canadian Agency for Drugs and Technologies in Health (CADTH) created a Patient and Community Advisory Committee. Twelve members bring lived experiences of chronic illness, progressive illness, mental illness, trauma, traveling long distances for treatment, and caregiving to an ill child, parent, or spouse. Members contribute their own insights and ideas but do not represent specific organizations or viewpoints. This paper explores how CADTH determined the committee's role, whether to have individuals or organizations as members, and how to recruit for diversity. The creation of this committee is changing how CADTH engages with patients.

摘要

为了认可患者在使用和参与公共资助的卫生系统方面所扮演的角色,加拿大药品和技术评估署(CADTH)成立了一个患者和社区咨询委员会。该委员会的 12 名成员具有慢性病、进行性疾病、精神疾病、创伤、长途跋涉求医和照顾患病儿童、父母或配偶的经历。成员们贡献了自己的见解和想法,但不代表特定的组织或观点。本文探讨了 CADTH 如何确定委员会的角色、是由个人还是组织担任成员,以及如何进行多样性招募。该委员会的成立正在改变 CADTH 与患者互动的方式。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验